著者: XuMingtong, SunKan, XuWenjie, WangChuan, YanDewen, LiShu, CongLi, PiYinzhen, SongWeihong, SunQingyuan, XiaoRijun, PengWeixia, WangJianping, PengHui, ZhangYawei, DuanPeng, ZhangMeiying, LiuJianying, HuangQingmei, LiXuefeng, BaoYan, ZengTianshu, WangKun, QinLi, WuChaoming, DengChunying, HuangChenghu, YanShuang, ZhangWei, LiMeizi, SunLi, WangYanjun, LiHongMei, WangGuang, PangShuguang, ZhengXianling, WangHaifang, WangFujun, SuXiuhai, MaYujin, LiZiling, XieZuoling, XuNing, NiLin, ZhangLi, DengXiangqun, PanTianrong, DongQijuan, WuXiaohong, ShenXingping, ZhangXin, ZouQijing, JiangChengxia, XiJue, MaJianhua, SunJingchao, YanLi

原題: Fotagliptin monotherapy with alogliptin as an active comparator in patients with uncontrolled type 2 diabetes mellitus: a randomized, multicenter, double-blind, placebo-controlled, phase 3 trial.

著者: MitaTomoya, KatakamiNaoto, YoshiiHidenori, OnumaTomio, KanetoHideaki, OsonoiTakeshi, ShiraiwaToshihiko, YasudaTetsuyuki, UmayaharaYutaka, YamamotoTsunehiko, YokoyamaHiroki, KuribayashiNobuichi, JinnouchiHideaki, GoshoMasahiko, ShimomuraIichiro, WatadaHirotaka

原題: Long-term efficacy and safety of early alogliptin initiation in subjects with type 2 diabetes: an extension of the SPEAD-A study.

著者: DimakosJenny, CuiYing, PlattRobert W, RenouxChristel, FilionKristian B, DourosAntonios

原題: Pharmacologic Heterogeneity and Risk of Severe Hypoglycemia with Concomitant Use of Sulfonylureas and DPP-4 Inhibitors: Population-Based Cohort Study.

著者: HsuChih-Neng, HsuanChin-Feng, LiaoDaniel, ChangJack Keng-Jui, ChangAllen Jiun-Wei, HeeSiow-Wey, LeeHsiao-Lin, TengSean I F

原題: Anti-Diabetic Therapy and Heart Failure: Recent Advances in Clinical Evidence and Molecular Mechanism.

著者: HaranoYumi, MitamuraYasutaka, JiangPeng, FujitaTakako, BabazonoAkira

原題: Risk heterogeneity of bullous pemphigoid among dipeptidyl peptidase-4 inhibitors: A population-based cohort study using Japanese Latter-Stage Elderly Healthcare Database.

著者: OguraToru, ShiraishiChihiro

原題: Comparison of Adverse Events Occurred During Administration of Dipeptidyl Peptidase-4 Inhibitor in Patients with Diabetes Using FDA Adverse Event Reporting System.

著者: ThanapairojeKoranit, JunsiritrakhoonSupanut, WichaiyoSurasak, OsmanMohd Azuraidi, SupharattanasitthiWasu

原題: Anti-ageing effects of FDA-approved medicines: a focused review.

著者: JonesLauren, JonesAlan M

原題: Suspected adverse drug reactions of the type 2 antidiabetic drug class dipeptidyl-peptidase IV inhibitors (DPP4i): Can polypharmacology help explain?

著者: LaymanSara N, ElliottWhitney V, NeuDaniel W, HowardTiffany G, HambyAaron

原題: Alogliptin and Heart Failure Outcomes in Patients With Type 2 Diabetes.

著者: OkadaKozo, KikuchiShinnosuke, KujiShotaro, NakayamaNaoki, MaejimaNobuhiko, MatsuzawaYasushi, IwahashiNoriaki, KosugeMasami, EbinaToshiaki, KimuraKazuo, TamuraKouichi, HibiKiyoshi

原題: Impact of early intervention with alogliptin on coronary plaque regression and stabilization in patients with acute coronary syndromes.

著者: SajalHarshit, PatilShashank M, RajRanjith, ShbeerAbdullah M, AgeelMohammed, RamuRamith

原題: Computer-Aided Screening of Phytoconstituents from <i>Ocimum tenuiflorum</i> against Diabetes Mellitus Targeting DPP4 Inhibition: A Combination of Molecular Docking, Molecular Dynamics, and Pharmacokinetics Approaches.

著者: MohantyDibyalochan, GilaniSadaf Jamal, ZafarAmeeduzzafar, ImamSyed Sarim, KumarLadi Alik, AhmedMohammed Muqtader, JahangirMohammed Asadullah, BakshiVasudha, AhmadWasim, EltayibEyman Mohamed

原題: Formulation and Optimization of Alogliptin-Loaded Polymeric Nanoparticles: In Vitro to In Vivo Assessment.

著者: ShahMuhammad Ajmal, HarisMuhammad, FaheemHafiza Ishmal, HamidAyesha, YousafRimsha, RasulAzhar, ShahGhulam Mujtaba, KhalilAtif Ali Khan, WahabAbdul, KhanHaroon, AlhasaniReem Hasaballah, AlthobaitiNorah A

原題: Cross-Talk between Obesity and Diabetes: Introducing Polyphenols as an Effective Phytomedicine to Combat the Dual Sword Diabesity.

著者: TerryDanielle, EadsAndrea V

原題: Alogliptin Induced Stomatitis: An Adverse Drug Event Case Report.

著者: PathakRashmi, KumarAvinash, PalfreyHenry A, StoneKirsten P, RajuNarayan R, GettysThomas W, MurthySubramanyam N

原題: Prolonged effects of DPP-4 inhibitors on steato-hepatitic changes in Sprague-Dawley rats fed a high-cholesterol diet.

著者: DuttaDeep, MohindraRitin, SuranaVineet, SharmaMeha

原題: Safety and efficacy of once weekly dipeptidyl-peptidase-4 inhibitor trelagliptin in type-2 diabetes: A meta-analysis.

著者: KimHae Jin, JeongIn Kyung, HurKyu Yeon, KimSoo-Kyung, NohJung Hyun, ChunSung Wan, KangEun Seok, RheeEun-Jung, ChoiSung Hee

原題: Comparison of Efficacy of Glimepiride, Alogliptin, and Alogliptin-Pioglitazone as the Initial Periods of Therapy in Patients with Poorly Controlled Type 2 Diabetes Mellitus: An Open-Label, Multicenter, Randomized, Controlled Study.

著者: DaluiSaikat K, ChakravertyRaja, YasminNafisha, PattanaikSmita, PanditKaushik, ChatterjeeSuparna

原題: Effects of DPP4 Inhibitors on Renal Outcomes in Diabetes Mellitus: A Systematic Review and Meta-Analysis.

著者: GaoBin, GaoWeiguo, WanHailong, XuFengmei, ZhouRong, ZhangXia, JiQiuhe

原題: Efficacy and safety of alogliptin versus acarbose in Chinese type 2 diabetes patients with high cardiovascular risk or coronary heart disease treated with aspirin and inadequately controlled with metformin monotherapy or drug-naive: A multicentre, randomized, open-label, prospective study (ACADEMIC).